Monica Kaminski Selected Research

Ceftibuten (Cedax)

4/2022

In Vitro and In Vivo Activity of Amoxicillin-Clavulanate Combined with Ceftibuten or Cefpodoxime Against Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Monica Kaminski Research Topics

Disease

1	Infections 04/2022
1	Gnathostomiasis 12/2019
1	Fever (Fevers) 01/2018
1	Leukocytosis (Pleocytosis) 01/2018
1	Lymphocele 01/2018
1	Weight Loss (Weight Reduction) 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2016
1	Alcoholism (Alcohol Abuse) 01/2016
1	Esophageal and Gastric Varices (Esophageal Varices) 01/2016
1	Siderosis 01/2016
1	Hemochromatosis (Bronze Diabetes) 01/2016
1	Breast Neoplasms (Breast Cancer) 01/2015

Drug/Important Bio-Agent (IBA)

1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 04/2022
1	Ceftibuten (Cedax)FDA Link 04/2022
1	CefpodoximeIBA 04/2022
1	Amoxicillin (Wymox)FDA LinkGeneric 04/2022
1	Praziquantel (Biltricide)FDA Link 12/2019
1	hydroxycitric acidIBA 01/2018
1	IronIBA 01/2016

Therapy/Procedure

1	Prostatectomy (Retropubic Prostatectomy) 01/2018
1	Surgical Portacaval Shunt (Portacaval Anastomosis) 01/2016
1	Blood Transfusion (Blood Transfusions) 01/2016
1	Operative Surgical Procedures 01/2015